Vital Signs - Contract Research and Manufacturing Services: Private Equity Interest and Strategy Shift

Vital Signs - Contract Research and Manufacturing Services: Private Equity Interest and Strategy Shift

 

RELEASE DATE
21-Sep-2009
REGION
North America
Research Code: 9561-00-96-00-00
SKU: HC00579-NA-MR_04052
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00579-NA-MR_04052
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on September 21, 2009, provides a strategic overview of recent investments and interest in the contract research and manufacturing sector (CRAMS) from private equity (PE) firms. Additionally, a company spotlight is provided for KBI Biopharma, a provider of drug development and manufacturing services to biopharmaceutical companies. Reimbursement and regulatory news from the FDA is also provided for the week of September 7, 2009.

Table of Contents

Related Research
This issue of Vital Signs, released on September 21, 2009, provides a strategic overview of recent investments and interest in the contract research and manufacturing sector (CRAMS) from private equity (PE) firms. Additionally, a company spotlight is provided for KBI Biopharma, a provider of drug development and manufacturing services to biopharmaceutical companies. Reimbursement and regulatory news from the FDA is also provided for the week of September 7, 2009.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-96-00-00
Is Prebook No